Introduction
In neuronal cells, Ca 2+ (Endo 1977; Lee 1997) . Cyclic ADP-ribose (cADPR) may be a second messenger or endogenous modulator of CICR, acting on specific subtypes of RyRs (Lee 1997 and Galione and Churchill 2002; Higashida et al. 2001a,b) : The cardiac and brain isoforms of type-2 RyRs and brain forms of type-3 RyRs are activated by cADPR (Sonnleitner et al. 1998 . Experiments with islet microsomes suggested that cADPR binds to FKBP12.6 on the RyRs, and the subsequent dissociation of FKBP12.6 from RyRs changes channel kinetics to release Ca 2+ (Noguchi et al. 1997) . The role of the cADPR-FKBP12.6-RyR2 complex in excitation-contraction coupling was also 5 proposed in smooth muscle cells (Wang et al. 2004) . However, the mechanism of action of cADPR on RyRs in neurons is not fully understood.
The use of specific agonists and/or antagonists provides a straightforward approach to decipher the intricate cellular mechanisms involving cADPR. Several partial agonists, hydrolysis-resistant agonists or antagonists have been described (Walseth and Lee 2002; Huang et al. 2002) . These agents were generated by enzymatic conversion from NAD + analogs, which were characterized using the Ca 2+ signaling system in invertebrate oocytes (Bailey et al. 1996; Bailey et al. 1997; Sethi et al. 1997; Ashamu et al. 1997) . It was shown that some of non-hydrolyzable mimics of cADPR have more potent Ca 2+ -releasing activity than cADPR (Zhang et al. 1996; Wong et al. 1999) . In addition, it was confirmed that the inosine congener of cADPR, cIDPR has Ca 2+ -releasing activity in intact T cells using the membrane-permeable form Kunerth et al. 2004) .
Recently, we performed total-synthesis of cyclic ADP-carbocyclic ribose (cADPcR) (Shuto et al. 2001) , its inosine congener (cyclic IDP-carbocyclic-ribose, cIDPcR) (Shuto et al. 1988), 8-chloro-cADPcR (8-Cl-cADPcR) , and 8-bromo-cIDPcR 6 (8-Br-cIDPcR) (Fukuoka et al. 2000) . These agents are hydrolysis-resistant mimics of cADPR with the oxygen atom in the N-1-ribose ring being replaced with a methylene group. Among these agents, cADPcR was shown to release Ca 2+ more effectively than cADPR in sea urchin eggs (Shuto et al. 2001; Shuto et al. 2003) , whereas an identical effect of cADPcR was not found in mammalian T cells (Guse et al. 2002) . Alterations at the 8-position of the adenine ring of cADPcR markedly altered the Ca 2+ release activity, which decreased efficiency for Ca 2+ release or developed antagonistic activity (Shuto et al. 2003) .
In mammalian neurons, Ca 2+ entry through N-and/or L-type VACCs facilitates the action of RyR Ca
2+
-release channels, known as the orthograde signal (Hua et al. 1996) .
This signal is enhanced in the presence of cADPR (Hua et al. 1996; Empson and Galione 1997; Hashii et al. 2000) . Depolarization-induced Ca 2+ entry augmented in the presence of cADPR, is inhibited by ryanodine in neurons (Hashii et al. 2000) . Thus, we assumed that cADPR-activated RyRs and VACCs are linked in a retrograde fashion (Chavis et al. 1996; Nakai et al. 1996) . However, more solid evidence is required to support this hypothesis.
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Therefore, we examined reciprocal functional coupling between ryanodine receptors and VACCs in voltage-clamped NG108-15 cells in the presence or absence of cADPR and synthetic cADPR analogues. We also examined whether cADPcR has an effect in mammalian neuronal cells.
Materials and Methods

Materials
cADPcR, cIDPcR, and 8-Br-cIDPcR were prepared as described previously (Shuto et al. 1988; Fukuoka et al. 2000) , and synthesis of 8-Cl-cADPcR was performed as described (Shuto et al. 2003) .
Cell Culture
NG108-15 neuroblastoma x glioma hybrid cells were cultured at 37˚C in 90 % air and 10% CO 2 in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 % fetal calf serum, 100 µM hypoxanthine, 0.1 µM aminopterin, and 16 µM thymidine (Higashida et al. 1990 ). Cells were differentiated in DMEM supplemented with hypoxanthine, thymidine, 1 % FCS and 0.25 mM dibutyryl cAMP for 7 days as described previously (Higashida et al. 1990 ).
Measurement of [Ca
Concentrations of [Ca 2+ ] i were determined microspectrofluorometrically using fura-2 in differentiated NG108-15 cells cultured on polylysine-coated glass coverslips. The cells were loaded with fura-2 using 5 µM fura-2 acetoxymethylester (fura-2 AM).
Fluorescence was measured at 36°C at determined sites through a pinhole (10 -20 µm in diameter) with alternating excitation wavelengths of 340 and 380 nm (Grynkiewicz et al. 1985 ) using a Ca 2+ microspectrofluorometric system (OSP-3 model, Olympus, Tokyo, Japan) (Hashii et al. 2000) .
Patch voltage-clamp and drug-application
Fura-2 AM-loaded NG108-15 cells were patch voltage-clamped in the whole-cell configuration as described previously (Higashida et al. 1990 ] i increases were measured during depolarization maintained for 1.6 -25 min (Hashii et al. 2000) .
Intracellular recording medium containing cADPR (10 µM), ADPR (10 and 300 µM), β-NAD + (100 µM), α-NAD + (100 µM), cADPcR (10 nM -100 µM), 8-Cl-cADPcR (10 µM), cIDPcR (10 µM), 8-Br-cIDPcR (10 µM), ruthenium red (10 µM) and 8-Br-cADPcR (10 µM) was applied by diffusion into the cytoplasm from the patch pipette.
Sources of compounds
cADPR was purchased from Yamasa Shoyu (Choshi, Japan). Fura-2 and fura-2 AM were purchased from Dojindo Laboratories (Kumamoto, Japan). Ryanodine, ADPR,
8-Br-cADPR and ruthenium red were purchased from Sigma Chemical Co. (St Louis, MO). Other chemicals were obtained from Wako Pure Chemicals (Osaka, Japan). ] i , similarly to previous reports regarding cADPR in sympathetic neurons (Hua et al. 1996) and in NG108-15 cells (Hashii et al. 2000) .
Results
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We then examined the role of cADPR analogues in [Ca 2+ ] i elevation at constant depolarization, in which [Ca 2+ ] i increased due to Ca 2+ influx through VACCs (Fig. 1d-f) . In control cells, [Ca 2+ ] i was increased by depolarization from -40 to -20 mV with an average peak value of 178 ± 15% (at the initial peak) and 130 ± 13% (after 5 min) of the 13 pre-depolarization level (n=3) (Fig. 1j) . In cells injected with 10 μM cADPcR, the same membrane depolarization induced significantly greater and persistent increases in [Ca 2+ ] i
( Fig. 1d) : the average [Ca 2+ ] i level was 318 ± 17% (at the initial peak) and 246 ± 9.2%
(after 5 min) of the pre-depolarization level (n=4). The increase by cADPcR was equivalent to or significantly greater than that evoked by 10 μM cADPR (Fig. 1g) . In contrast, 10 μM ] i level was 186 ± 6% (at the initial peak) and 140 ± 13% (after 5 min) of the pre-depolarization level (n=4). These results are in agreement with the previous report 14 in the sea urchin egg (Sethi et al. 1996) , and suggest that β-NAD
] i elevation is mediated by its conversion to cADPR by the intrinsic ADP-ribosyl cyclase in NG108-15 cells (Higashida et al. 2000b; Hashii et al. 2000) . Activation of the RyR by caffeine and ryanodine (Sitsapesan et al. 1995 ] i at -10 mV were 211 ± 26%, 198 ± 26%, and 173% ± 8%, respectively (n=4). ] i levels at -10 mV were 108 ± 8% and 123 ± 12%, respectively (n=4).
In cADPcR-infused cells, the depolarization-induced [Ca
These results suggest that cADPcR amplified CICR triggered by the activation of VACCs, in the same manner as the action of cADPR in neuronal cells (Hua et al. 1996; Empson and Galione 1997; Hashii et al. 2000) .
cADPR is hydrolyzed to ADP-ribose (ADPR) by cADPR hydrolases such as CD38 in neurons (Higashida et al. 2001b) . It was recently demonstrated that free ADPR gates the calcium-permeable cation channels (LTRPC2/TrpC7) (Perraud et al. 2001; Kuhn and Luckhoff 2004) , which is expressed at high levels in neurons (Perraud et al. 2001 ).
This finding prompted us to examine the involvement of ADPR in our system. ADPR slightly potentiated the depolarization-induced increase in [Ca 2+ ] i , although the effect was not statistically significant: The level of [Ca 2+ ] i at -10 mV was 168 ± 12% of that at -40 mV (n = 5). ADPR had no effect on hyperpolarization-activated Ca 2+ influx in NG108-15 cells ( Fig. 3g and 4c) . Thus, no relationship was found between ADPR and CICR in NG108-15 cells.
The interfering effects of 8-Cl-cADPcR and 8-Br-cADPR were examined in co-infused cells, as several cADPR analogues modified at the 8-position of the adenine group have antagonistic activities against cADPR-induced Ca 2+ release (Walseth and Lee 1993) . Depolarization-induced increases in [Ca 2+ ] i were significantly decreased by co-injection of 8-Cl-cADPcR or 8-Br-cADPR from the potentiated level by cADPcR alone 17 ( Fig. 5a and c) . In addition, the depolarization-induced increases in [Ca 2+ ] i were significantly decreased by co-injection of 8-Cl-cADPcR or 8-Br-cADPR from the potentiated level by cADPR alone (Fig. 5b and c) .
Discussion
The present results show that a stable analogue of cADPR, cADPcR, applied through a patch pipette did not trigger the [Ca 2+ ] i increase by itself under the clamp conditions used in the present study, but potentiated [Ca 2+ ] i increases induced by activation of VACCs, similarly to the endogenous ligand, cADPR (Sitsapesan et al. 1995) . Thus, we concluded that cADPcR is an agonist and that 8-Cl-cADPcR is an antagonist of the ryanodine-involving reaction in mammalian neuronal cells. The results of the present study indicate that the NG108-15 cell system is unique and useful for characterizing analogues, although the structure-activity relationships of cADPR analogues have not been fully characterized, in comparison with that of sea urchin egg microsomes or T-lymphocytes (Guse et al. 1999 and Lee 1993 and . ] i elevation due to the activation of L-type VACCs, peaking at -10 or 0 mV (Hashii et al. 2000) . Thus, the peak induced by cADPcR was shifted to the left by more than -10 mV. This indicates that L-type VACCs are considerably sensitized by cADPcR, and suggests that cADPcR is more active than cADPR. However, although it is less likely, the present study did not exclude the possibility that the cADPcR-induced potentiation of Ca 2+ increases is due to the recruitment of different types of VACCs, such as T-or N-types found in NG108-15 cells (Higashida et al. 1990 ).
The cADPcR-induced augmentation in rodent NG108-15 cells is similar to that in sea urchin eggs (Shuto et al. 2001) . However, injection of cADPcR itself can induce increases in [Ca 2+ ] i in sea urchin eggs, but not in NG108-15 cells. This is not surprising because cADPR can act as a direct ligand to induce [Ca 2+ ] i increases in sea urchin eggs, while in mammalian neurons, cADPR is not a direct ligand, but is an indirect modulator of Ca 2+ increases (Hua et al. 1996; Empson and Galione 1997; Hashii et al. 2000) . The increase induced by the derivative was 5 to 7-fold greater than that induced by native cADPR in the sea urchin, although it was less than 2-fold in mammalian neurons. Thus, the peak level of cADPcR-evoked Ca 2+ concentrations reached 3 μM in sea urchin eggs (Shuto et al. 2001) , whereas it reached only 200 -300 nM in the present study. These observations indicate that the non-hydrolytic property of cADPcR is effective in neuronal cells. Ca 2+ release in permeabilized T cells was also directly activated by cADPcR, but was much less effective than that by cADPR (Guse et al. 1999 and . The discrepancy in the sensitivity of cADPcR between different cell types may be explained in part by the diversity of cADPR binding proteins.
We demonstrated an antagonistic effect of 8-Cl-cADPcR against both cADPcR and cADPR (Fig. 5) . Generally, substitution with amino (8-NH 2 ), azido (8-N 3 ), or bromo (8-Br) groups at the 8-position of the adenine ring produces an antagonistic effect on cADPR-induced Ca 2+ release in various biological systems (Walseth and Lee 2002) , including sea urchin eggs (Walseth and Lee 1993) and T lymphocytes (Guse et al. 1999 and . This is also true of cADPcR with 8-Cl substitution. Our findings in Fig. 5 suggest that cADPcR acts on the same site as cADPR, and that 8-Cl-cADPcR competes for Further studies are required to determine if 8-Cl-cADPcR behaves as a partial agonist as described previously in the sea urchin (Shuto et al. 2003) .
Another stable mimic, cIDPcR, differs structurally from cADPcR in that the adenine ring has been replaced by hypoxanthine linked to the "Northern ribose" via N-1 (Fukuoka et al. 2000) . As the conformation of cIDPcR was considered to be similar to that of cADPcR, cIDPcR should play a role in Ca 2+ mobilization. It was recently reported that stable cIDPR mimics have strong Ca 2+ release activity in rat brain microsomes and intact HeLa cells (Huang et al. 2002) . However, cIDPcR did not cause such strong amplification in NG108-15 cells as far as we tested at 10μM. As cIDPR analogues are anticipated as therapeutic agents (Huang et al. 2002) , it is necessary to define the efficiency of other stable cIDPR mimics in this neuronal system.
In conclusion, cADPcR, a stable mimic of cADPR, enhances the depolarization-induced Ca 2+ increase that is antagonized by co-injection with 8-Cl-cADPcR.
These results indicated the presence of functional reciprocal coupling between RyRs and
VACCs via cADPR, which was revealed by cADPcR and antagonized by 8-Cl-cADPcR. ] i levels were plotted at the peak after depolarization to -20 mV, and are given as percentages of that at -40 mV. Each symbol is mean ± S.E.M. of 3 -4 experiments. *, Values in cells
Figure legends
